Modeling study for optimization of skin dose for partial breast irradiation using Xoft Axxent electronic brachytherapy applicator

Brachytherapy

Volumn 9, Issue 1, 2010, Pages 81-85

  Hepel, Jaroslaw T ^a,b   Hiatt, Jessica R ^a,b   Cardarelli, Gene A ^a,b   Wazer, David E ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Balloon brachytherapy; Breast cancer; Electronic brachytherapy; Skin dose; Xoft Axxent

Indexed keywords

ANISOTROPY; ARTICLE; BALLOON CATHETER; BRACHYTHERAPY; BREAST CANCER; CANCER RADIOTHERAPY; DOSIMETER; DOSIMETRY; HISTOGRAM; PARTIAL BODY RADIATION; PHANTOM; PRIORITY JOURNAL; RADIATION APPLICATOR; RADIATION DOSE; REPRODUCIBILITY; TREATMENT PLANNING;

BALLOON DILATATION; BRACHYTHERAPY; BREAST NEOPLASMS; COMPUTER SIMULATION; FEMALE; HUMANS; MODELS, BIOLOGICAL; PROSTHESIS IMPLANTATION; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SKIN;

EID: 72449134734     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2009.08.005     Document Type: Article

References (23)

1. Veronesi U., Cascinelli N., Mariani L., et al. Twenty year follow up of a randomized study of comparing breast conserving surgery with radical mastectomy for early stage breast cancer. N Engl J Med 347 (2002) 1227-1232
2. Fisher B., Anderson S., Bryant J., et al. Twenty year follow up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
3. Fisher E.R., Sass R., Fisher B., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6): Relationship of local recurrence to multicentricity. Cancer 57 (1986) 1717-1724
4. Fisher E.R., Anderson S., Redmond C., et al. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: Pathologic findings from NSABP protocol B-06. Semin Surg Oncol 8 (1992) 161-166
5. Gage I., Recht A., Gelman R., et al. Long-term outcome following breast conserving surgery, and radiation therapy. Int J Radiat Oncol Biol Phys 33 (1995) 245-251
6. Wazer D.E., Schmidt-Ullrich R.K., Schmid C., et al. Factors determining outcome for breast-conserving irradiation with margin directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys 40 (1998) 851-858
7. Vicini F., Kestin L., Chen P., et al. Limited-field radiation therapy in the management of early stage breast cancer. J Natl Cancer Inst 95 (2003) 1205-1210
8. King T.A., Bolton J.S., Kuske R.R., et al. Long term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is, 1, 2) breast cancer. Am J Surg 180 (2000) 1148-1153
9. Polgar C., Major T., Fodor J., et al. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast conserving surgery: Seven year results of a comparative study. Int J Radiat Oncol Biol Phys 60 (2004) 1173-1181
10. Wazer D.E., Berle L., Graham R., et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys 53 (2002) 889-897
11. Niehoff P., Polgar C., Ostertag H., et al. Clinical experience with MammoSite radiation therapy system for brachytherapy of breast cancer: Results from an international phase II trial. Radiother Oncol 79 (2006) 316-320
12. Keisch M., Vicini F., Kuske R.R., et al. Thirty-nine months results with the MammoSite brachytherapy applicator: Details regarding cosmesis, toxicity and local control in partial breast irradiation. Int J Radiat Oncol Biol Phys 63 (2005) 10 [abstract]
13. Rivard M.J., Davis S.D., DeWerd L.A., et al. Calculated and measured brachytherapy dosimetry parameters in water for the Xoft Axxent x-ray source: An electronic brachytherapy source. Med Phys 33 (2006) 4020-4032
14. Danzer J., Dudney C., Seibert R., et al. Optically stimulated luminescence of aluminum oxide detectors for radiation therapy quality assurance. Med Phys 34 (2007) 2628-2629 [abstract]
15. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
16. Stolier A.J., Fuhrman G.M., Scroggins T.G., and Boyer C.I. Post-lumpectomy insertion of MammoSite brachytherapy device using the scar entry technique: Initial experience and technical considerations. Breast J 11 (2005) 199-203
17. Turreson I. Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiat Oncol Biol Phys 19 (1990) 1569-1574
18. Wazer D.E., Kaufman S., Cuttino L., et al. Accelerated partial breast irradiation: An analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys 64 (2006) 489-495
19. Perera F., Chisela F., Stitt L., et al. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer. Int J Radiat Oncol Biol Phys 62 (2005) 1283-1290
20. Turesson I., and Notter G. The predictive value of skin telangiectasia for late radiation effects in different normal tissues. Int J Radiat Oncol Biol Phys 12 (1986) 603-609
21. Edmundson G.K., Vicini F.A., Chen P.Y., et al. Dosimetric characteristics of the Mammosite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 52 (2002) 1132-1139
22. Astrahan M.A., Jozsef G., and Steeter O.E. Optimization of Mammosite therapy. Int J Radiat Oncol Biol Phys 58 (2004) 220-232
23. Dickler A., Kirk M.C., Griem K., et al. A dosimetric comparison of MammoSite high-dose-rate brachytherapy and Xoft Axxent electronic brachytherapy. Brachytherapy 6 (2007) 164-168